David S. Segal

University of California, San Diego, La Jolla, CA 
"David Segal"
Mean distance: 14.24 (cluster 19)


Sign in to add trainee
Peter Todd research assistant 1992-1994 UCSD
Amy F. Arnsten grad student 1976-1982 UCSD Neurosciences
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bolton K, Segal D, Walder K. (2012) The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetes. Biologics : Targets & Therapy. 6: 67-72
Burns CJ, Fantino E, Powell AK, et al. (2011) The microtubule depolymerizing agent CYT997 causes extensive ablation of tumor vasculature in vivo. The Journal of Pharmacology and Experimental Therapeutics. 339: 799-806
Wetzler M, Segal D. (2011) Omacetaxine as an anticancer therapeutic: what is old is new again. Current Pharmaceutical Design. 17: 59-64
Bozaoglu K, Curran JE, Stocker CJ, et al. (2010) Chemerin, a novel adipokine in the regulation of angiogenesis. The Journal of Clinical Endocrinology and Metabolism. 95: 2476-85
Bolton K, Segal D, McMillan J, et al. (2009) Identification of secreted proteins associated with obesity and type 2 diabetes in Psammomys obesus. International Journal of Obesity (2005). 33: 1153-65
Kuczenski R, Segal DS, Melega WP, et al. (2009) Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2430-41
Su H, Gunter JH, de Vries M, et al. (2009) Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesity. Biochemical and Biophysical Research Communications. 386: 351-5
Bozaoglu K, Segal D, Shields KA, et al. (2009) Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. The Journal of Clinical Endocrinology and Metabolism. 94: 3085-8
Segal DS, Stockwell T. (2009) Low alcohol alternatives: a promising strategy for reducing alcohol related harm. The International Journal On Drug Policy. 20: 183-7
Bolton K, Segal D, McMillan J, et al. (2008) Decorin is a secreted protein associated with obesity and type 2 diabetes. International Journal of Obesity (2005). 32: 1113-21
See more...